EMERGENT BIOSOLUTIONS INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value
EMERGENT BIOSOLUTIONS INC. (EBS) had Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value of $4.30 million as of 2024-06-30, per its 10-Q filed 2024-08-07.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue · last filed 2024-08-07
- 2024-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $4.30M.
- 2024-03-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $5.50M.
- 2023-12-31: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $5.60M.
- 2023-06-30: Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value $7.40M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value as first filed |
|---|---|---|
| 2024-06-30 | $4.30M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $5.50M 10-Q · filed 2024-08-07 | |
| 2023-12-31 | $5.60M 10-Q · filed 2024-08-07 | |
| 2023-06-30 | $7.40M 10-Q · filed 2024-08-07 | |
| 2023-03-31 | $7.60M 10-Q · filed 2024-08-07 | |
| 2022-12-31 | $8.00M 10-Q · filed 2024-08-07 | $6.80M 10-K · filed 2023-03-01 |
| 2022-09-30 | $7.80M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $8.10M 10-Q · filed 2022-08-02 | |
| 2022-03-31 | $7.60M 10-Q · filed 2022-04-29 | |
| 2021-12-31 | $38.40M 10-K · filed 2024-03-08 | $37.20M 10-K · filed 2022-02-25 |
| 2021-09-30 | $37.70M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $38.10M 10-Q · filed 2021-07-30 | |
| 2021-03-31 | $38.00M 10-Q · filed 2021-04-30 | |
| 2020-12-31 | $59.30M 10-K · filed 2024-03-08 | $58.10M 10-K · filed 2021-02-19 |
| 2020-09-30 | $58.30M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $29.20M 10-Q · filed 2020-07-31 | |
| 2020-03-31 | $29.10M 10-Q · filed 2020-05-01 | |
| 2019-12-31 | $30.40M 10-K/A · filed 2023-12-11 | $29.20M 10-K · filed 2020-02-25 |
| 2019-09-30 | $70.20M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $65.00M 10-Q · filed 2019-08-02 | |
| 2019-03-31 | $72.70M 10-Q · filed 2019-05-08 | |
| 2018-12-31 | $60.00M 10-K · filed 2021-02-19 | $60.00K 10-K · filed 2019-02-22 |
| 2018-09-30 | $11.96M 10-Q · filed 2018-11-02 | |
| 2018-06-30 | $12.69M 10-Q · filed 2018-08-03 | |
| 2018-03-31 | $12.47M 10-Q · filed 2018-05-04 | |
| 2017-12-31 | $12.30M 10-K · filed 2020-02-25 | $12.27M 10-K · filed 2018-02-23 |
| 2017-09-30 | $11.79M 10-Q · filed 2017-11-03 | |
| 2017-06-30 | $11.21M 10-Q · filed 2017-08-04 | |
| 2017-03-31 | $11.82M 10-Q · filed 2017-05-05 | |
| 2016-12-31 | $13.20K 10-K · filed 2019-02-22 | $13.19M 10-K · filed 2017-02-28 |
| 2016-09-30 | $22.93M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $25.56M 10-Q · filed 2016-08-05 | |
| 2016-03-31 | $25.69M 10-Q · filed 2016-05-06 | |
| 2015-12-31 | $25.16M 10-K · filed 2018-02-23 | $25.60M 10-K · filed 2016-02-29 |
| 2015-09-30 | $24.76M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $36.84M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $48.45M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $40.04M 10-K · filed 2017-02-28 | $47.66M 10-K · filed 2015-03-09 |
| 2014-09-30 | $19.23M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $23.01M 10-Q · filed 2014-08-08 | |
| 2014-03-31 | $22.32M 10-Q · filed 2014-05-12 | |
| 2013-12-31 | $16.62M 10-K · filed 2016-02-29 | |
| 2013-09-30 | $16.58M 10-Q · filed 2013-11-08 | |
| 2012-12-31 | $0.00 10-K · filed 2015-03-09 | |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-03 | |
| 2011-12-31 | $4.75M 10-K · filed 2014-03-10 | |
| 2010-12-31 | $14.53M 10-K · filed 2013-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |